Inventor · disambiguated record
Gabriel Galvin
Also filed as: GALVIN GABRIEL · GALVIN GABRIEL M
11 granted patents·6 pending applications·37 citations·filing 2003–2022
86Inventor score
Files withINTERCEPT PHARMACEUTICALS INC6ARDEA BIOSCIENCES INC3BRISTOL MYERS SQUIBB CO3GALVIN GABRIEL1INTERCEPT PHARMACEUTICAL INC1
Top patents by PatentIndex Score
17 records- 0192US7186846B2Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed thereinBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Mar 6, 2007·18 cites·1 claims
- 0281US8546436B2Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid and uses thereofTREIBER LASZLO R·Filed 2011·Granted Oct 1, 2013·6 cites·11 claims
- 0380US11066437B2Methods and intermediates for the preparation of bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Jul 20, 2021·2 cites·22 claims
- 0478US7420063B2Process for preparing a dipeptidyl peptidase IV inhibitor and intermediates employed thereinBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Sep 2, 2008·2 cites·19 claims
- 0577US8524754B2Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio) acetate, and uses thereofZAMANSKY IRINA·Filed 2011·Granted Sep 3, 2013·6 cites·20 claims
- 0670US9296709B2Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acidARDEA BIOSCIENCES INC·Filed 2013·Granted Mar 29, 2016·1 cites·9 claims
- 0762US2023057232A1Isotopically labeled bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 0858US11472831B2Isotopically labeled bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2018·Granted Oct 18, 2022·0 cites·15 claims
- 0957US7172884B2Methods for the preparation, isolation and purification of epothilone B, and x-ray crystal structures of epothilone BBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Feb 6, 2007·2 cites·21 claims
- 1054US2022127302A1Methods and intermediates for the preparation of bile acid derivativesINTERCEPT PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 1149US2013345271A1Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetate, and uses thereofARDEA BIOSCIENCES INC·Filed 2013·Application pending·0 cites
- 1243US2016214947A1Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acidARDEA BIOSCIENCES INC·Filed 2016·Application pending·0 cites
- 1342US10604545B2Methods for the preparation of obeticholic acid and derivatives thereofINTERCEPT PHARMACEUTICAL INC·Filed 2016·Granted Mar 31, 2020·0 cites·16 claims
- 1441US2006035954A1Ammonolysis process for the preparation of intermediates for DPP IV inhibitorsSHARMA PADAM N·Filed 2005·Application pending·0 cites
- 1538US8222413B2Methods for synthesizing heterocyclic compoundsGALVIN GABRIEL·Filed 2006·Granted Jul 17, 2012·0 cites·23 claims
- 1638US2021139528A1Crystalline forms of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1737US10604544B2Methods for preparation of bile acids and derivatives thereofINTERCEPT PHARMACEUTICALS INC·Filed 2016·Granted Mar 31, 2020·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Gabriel Galvin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →